Home Medicine Measurement of Serum β-Crosslaps Is Influenced by Proteolytic Conditions
Article
Licensed
Unlicensed Requires Authentication

Measurement of Serum β-Crosslaps Is Influenced by Proteolytic Conditions

  • Markus Herrmann , Gerd Pape and Wolfgang Herrmann
Published/Copyright: June 1, 2005
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 40 Issue 8

Abstract

Serum β-crosslaps are an established laboratory test to investigate bone metabolism. However, lytic conditions may affect the measurement of serum β-crosslaps. Therefore, we investigated the effect of cathepsin C and human leukocyte lysate on serum β-crosslaps in relation to temperature and time. We divided eight serum samples with elevated β-crosslaps levels into three aliquots and stored them at 4, 21 and 37°C. Another five serum samples were divided into three aliquots and adjusted to contain different cathepsin C concentrations (50, 250, 500 IU/l). These aliquots were divided again and stored at 4, 21 and 37°C. Finally, three aliquots from three additional serum samples were treated with human leukocyte lysate (100, 300, 500 IU/I), divided again and stored at 4, 21 and 37°C. Measurements of serum β-crosslaps were then carried out before and immediately after manipulation, and after 2 and 5 days of storage. When stored at 21°C, serum β-crosslaps diminished significantly (25% after 5 days), but no significant change was detectable when they were stored at 4°C. Cathepsin C induced up to a 14% increase in β-crosslaps while human leukocyte lysate caused up to a 17% decrease.

This study demonstrates that the influence of proteolytic conditions on the serum concentration of β-crosslaps is not uniform. Leukocyte lysate decreased serum β-crosslaps while the addition of cathepsin C increased their concentration. Therefore, serum should be separated from the whole blood immediately after coagulation and stored until analysis in a deep freezer.

:
Published Online: 2005-06-01
Published in Print: 2002-08-26

Copyright © 2002 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. SIBioC 2002 - 34th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, Rimini, Italy, 17-20 September 2002
  2. Santorini Biologie Prospective Conference 2002 From Genetic Variations to Risk Prediction and Pharmacogenomics Santorini, Greece, 25-28 September 2002
  3. CCLM Special Issue on Diabetes Mellitus - Call for Papers
  4. Pathophysiological and Clinical Relevance of Circulating Levels of Cardiac Natriuretic Hormones: Are They Merely Markers of Cardiac Disease?
  5. Comparative Measurement of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide in Ambulatory Patients with Heart Failure
  6. Tumor Necrosis Factor-α-Induced Accumulation of Tumor Suppressor Protein p53 and Cyclin-dependent Protein Kinase Inhibitory Protein p21 Is Inhibited by Insulin in ME-180S Cells
  7. Inflammatory Response to Coronary Stent Implantation in Patients with Unstable Angina
  8. Immature Granulocyte Count after Liver Transplantation
  9. An Ideal Substrate for the Measurement of Pancreatic Amylase?
  10. Defining the Period of Recovery of the Glucose Concentration after Its Local Perturbation by the Implantation of a Miniature Sensor
  11. Measurement of Serum β-Crosslaps Is Influenced by Proteolytic Conditions
  12. Quantitative Determination of Faecal Fatty Acids and Triglycerides by Fourier Transform Infrared Analysis with a Sodium Chloride Transmission Flow Cell
  13. Rapid Identification of Atypical Variant of Plasma Butyrylcholinesterase by PCR
  14. Determination of Nitrite Plus Nitrate and Malondialdehyde in Human Plasma: Analytical Performance and the Effect of Smoking and Exercise
  15. Iron Status in Black Persons Is Not Influenced by Haptoglobin Polymorphism
  16. Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency in the Eastern Province of Saudi Arabia
  17. Comparison of Urine Cell Characteristics by Flow Cytometry and Cytology in Patients Suspected of Having Bladder Cancer
  18. Clinical Validation of a Fully Automated 17β-Estradiol and Progesterone Assay (VIDAS®) for Use in Monitoring Assisted Reproduction Treatment
  19. Evaluation of a Commercially Available Serologic Assay for Antibodies against Tuberculosis-associated Glycolipid Antigen
  20. Evaluation of Two Modified Cardiac Troponin I Enzyme Immunoassays
  21. Evaluation of Denka-Seiken Turbidimetric High-Sensitivity C-Reactive Protein Assay
  22. Amiodarone and Desethylamiodarone Bind to Barrier Gels in Serum Separator Blood Collection Tubes
  23. A Novel Explanation for Low Alanine Aminotransferase Activity in Human Serum Caused by IgG Inhibitor
  24. Serum Total Antioxidant Status Is Higher in Postmenopausal Women and after Estrogen Replacement Therapy
  25. Immunoturbidimetric Assay for Serum Cystatin C Using the Cobas Fara Analyzer
  26. Meetings and Awards
Downloaded on 8.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2002.136/html
Scroll to top button